Growing a pharma business requires a strategic approach considering the specific context of your company and the pharmaceutical industry as a whole. Here are some general pointers to get you started: Market and Customer: Identify your target customer: Deeply understand the specific needs and challenges of your target audience, whether it's doctors, patients, hospitals, or other healthcare providers. This helps tailor your products, services, and marketing efforts. Focus on unmet needs: Look for gaps in the market where existing solutions are inadequate or unavailable. Addressing unmet needs can give you a competitive edge and drive innovation. Track market trends: Stay updated on regulatory changes, technological advancements, and emerging diseases to adapt your approach and anticipate future opportunities. Products and Services: Invest in R&D: Develop innovative products or differentiate existing ones through unique formulations, delivery methods, or combinations. Remember
Schedules: Schedule A, Schedule B, Schedule C, Schedule D, Schedule E1, Schedule F, Schedule G, Schedule H, Schedule H1, Schedule I, Schedule J, Schedule K, Schedule L1, Schedule M, Schedule M1, Schedule M2, Schedule M3, Schedule N, Schedule O, Schedule P, Schedule Q, Schedule R, Schedule S, Schedule T, Schedule U, Schedule V, Schedule W, Schedule X, Schedule Y
Schedule D (Rule 43) is related to import of drugs into India. Schedule D provides information about extent and condition of exemption for a class of drug in case of import.
Schedule D(I)(Rule 21D and 24A): Information and undertaking required to be submitted by the manufacturer or his authorized agent with the Application Form for a Registration Certificate. The format shall be properly filled in for each application in Form 40.
The detailed information, secret in nature, may be furnished on a Computer Floppy.
Schedule D(II) (Rule 21D and 24A): Information required to be submitted by the manufacturer or his authorized agent with the Application Form for the registration of a bulk drug/formulation/special product for its import into India.
The format shall be properly filled in and the detailed information, secret in nature, may be furnished on a Computer Floppy.
Annexure A: Information to be Submitted In Schedule D-II: Specific information required for the Blood Product
Annexure B: Information to be submitted in schedule D-II: specific information required for the diagnostic kits
Annexure C: Information to be submitted in schedule D-II: Specific information required for the vaccines
Schedule D(III)(Rule 129A): Information and undertaking required to be submitied by the manufacturer or his authorised importer/distributor/agent with the application form for a registration certificate.
For more detail refer Drug and Cosmetic Act
Schedule D (Rule 43) is related to import of drugs into India. Schedule D provides information about extent and condition of exemption for a class of drug in case of import.
Schedule D(I)(Rule 21D and 24A): Information and undertaking required to be submitted by the manufacturer or his authorized agent with the Application Form for a Registration Certificate. The format shall be properly filled in for each application in Form 40.
The detailed information, secret in nature, may be furnished on a Computer Floppy.
Schedule D(II) (Rule 21D and 24A): Information required to be submitted by the manufacturer or his authorized agent with the Application Form for the registration of a bulk drug/formulation/special product for its import into India.
The format shall be properly filled in and the detailed information, secret in nature, may be furnished on a Computer Floppy.
Annexure A: Information to be Submitted In Schedule D-II: Specific information required for the Blood Product
Annexure B: Information to be submitted in schedule D-II: specific information required for the diagnostic kits
Annexure C: Information to be submitted in schedule D-II: Specific information required for the vaccines
Schedule D(III)(Rule 129A): Information and undertaking required to be submitied by the manufacturer or his authorised importer/distributor/agent with the application form for a registration certificate.
For more detail refer Drug and Cosmetic Act
Comments
Post a Comment